GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Eucrates Biomedical Acquisition Corp (NAS:EUCRW) » Definitions » ROE % Adjusted to Book Value

Eucrates Biomedical Acquisition (Eucrates Biomedical Acquisition) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Eucrates Biomedical Acquisition ROE % Adjusted to Book Value?

Eucrates Biomedical Acquisition's ROE % for the quarter that ended in Dec. 2022 was 1.03%. Eucrates Biomedical Acquisition's PB Ratio for the quarter that ended in Dec. 2022 was N/A. Eucrates Biomedical Acquisition's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2022 was N/A.


Eucrates Biomedical Acquisition ROE % Adjusted to Book Value Historical Data

The historical data trend for Eucrates Biomedical Acquisition's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eucrates Biomedical Acquisition ROE % Adjusted to Book Value Chart

Eucrates Biomedical Acquisition Annual Data
Trend Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
- - -

Eucrates Biomedical Acquisition Quarterly Data
Aug20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Eucrates Biomedical Acquisition's ROE % Adjusted to Book Value

For the Shell Companies subindustry, Eucrates Biomedical Acquisition's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eucrates Biomedical Acquisition's ROE % Adjusted to Book Value Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Eucrates Biomedical Acquisition's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Eucrates Biomedical Acquisition's ROE % Adjusted to Book Value falls into.



Eucrates Biomedical Acquisition ROE % Adjusted to Book Value Calculation

Eucrates Biomedical Acquisition's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=4.49% / N/A
=N/A

Eucrates Biomedical Acquisition's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=1.03% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eucrates Biomedical Acquisition ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Eucrates Biomedical Acquisition's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Eucrates Biomedical Acquisition (Eucrates Biomedical Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
250 West 55th Street, Suite 13D, New York, NY, USA, 10019
Website
Eucrates Biomedical Acquisition Corp is a blank check company.

Eucrates Biomedical Acquisition (Eucrates Biomedical Acquisition) Headlines